A streptozotocin-induced diabetic neuropathic pain model for static or dynamic mechanical allodynia and vulvodynia: validation using topical and systemic gabapentin.

Abstract

Neuropathic vulvodynia is a state of vulval discomfort characterized by a burning sensation, diffuse pain, pruritus or rawness with an acute or chronic onset. Diabetes mellitus may cause this type of vulvar pain in several ways, so this study was conducted to evaluate streptozotocin-induced diabetes as a neuropathic pain model for vulvodynia in female rats. The presence of streptozotocin (50 mg/kg i.p.)-induced diabetes was initially verified by disclosure of pancreatic tissue degeneration, blood glucose elevation and body weight loss 5-29 days after a single treatment. Dynamic (shortened paw withdrawal latency to light brushing) and static (diminished von Frey filament threshold pressure) mechanical allodynia was then confirmed on the plantar foot surface. Subsequently, both static and dynamic vulvodynia was detected by application of the paradigm to the vulval region. Systemic gabapentin (75 mg/kg, i.p.) and topical gabapentin (10 % gel) were finally tested against allodynia and vulvodynia. Topical gabapentin and the control gel vehicle significantly increased paw withdrawal threshold in the case of the static allodynia model and also paw withdrawal latency in the model for dynamic allodynia when compared with the streptozotocin-pretreated group. Likewise, in the case of static and dynamic vulvodynia, there was a significant antivulvodynia effect of systemic and topical gabapentin treatment. These outcomes substantiate the value of this model not only for allodynia but also for vulvodynia, and this was corroborated by the findings not only with systemic but also with topical gabapentin.

• Authors: Gowhar Ali, Fazal Subhan, Muzaffar Abbas, Jehan Zeb, Muhammad Shahid, Robert D E Sewell
• Journal: Naunyn-Schmiedeberg's archives of pharmacology (Naunyn Schmiedebergs Arch Pharmacol) Vol. 388 Issue 11 Pg. 1129-40 (Nov 2015) ISSN: 1432-1912 [Electronic] Germany
• PMID: 26134846 (Publication Type: Journal Article)

Chemical References

• Amines
• Analgesics
• Cyclohexanecarboxylic Acids
• gamma-Aminobutyric Acid
• Gabapentin

Topics

• Administration, Topical
• Amines (administration & dosage, therapeutic use)
• Analgesics (administration & dosage, therapeutic use)
• Animals
• Cyclohexanecarboxylic Acids (administration & dosage, therapeutic use)
• Diabetes Mellitus, Experimental (drug therapy)
• Diabetic Neuropathies (drug therapy)
• Disease Models, Animal
• Female
• Gabapentin
• Hyperalgesia (drug therapy)
• Injections
• Neuralgia (drug therapy)
• Rats, Sprague-Dawley
• Vulvodynia (drug therapy)
• gamma-Aminobutyric Acid (administration & dosage, therapeutic use)